Literature DB >> 1316240

Cooperativity in transactivation between retinoic acid receptor and TFIID requires an activity analogous to E1A.

A Berkenstam1, M M Vivanco Ruiz, D Barettino, M Horikoshi, H G Stunnenberg.   

Abstract

In embryonal carcinoma (EC) cells retinoic acid (RA) strongly induces transcription from the RA receptor beta 2 (RAR beta 2) promoter through an RA response element (RARE) located in close proximity to the TATA box. Here we demonstrate that recombinant human TATA box-binding protein, hTFIID, and RAR functionally cooperate in transactivation of the RAR beta 2 promoter in EC cells in a strictly RA-dependent manner. We demonstrate that the core domain of hTFIID is sufficient to mediate RAR-dependent transcription and that Drosophila, but not yeast, TFIID can substitute for hTFIID. In COS cells ectopic expression of the E1A protein is a prerequisite for hTFIID and RAR to cooperate in transactivation. We propose a model for transcriptional regulation of the RAR beta 2 promoter in EC cells in which RAR, following activation by RA, functionally interacts with hTFIID via an E1A-like activity present in EC cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1316240     DOI: 10.1016/0092-8674(92)90443-g

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  42 in total

1.  Cleavage and proteasome-mediated degradation of the basal transcription factor TFIIA.

Authors:  Torill Høiby; Dimitra J Mitsiou; Huiqing Zhou; Hediye Erdjument-Bromage; Paul Tempst; Hendrik G Stunnenberg
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

2.  p300 is involved in formation of the TBP-TFIIA-containing basal transcription complex, TAC.

Authors:  Dimitra J Mitsiou; Hendrik G Stunnenberg
Journal:  EMBO J       Date:  2003-09-01       Impact factor: 11.598

3.  UTF1, a novel transcriptional coactivator expressed in pluripotent embryonic stem cells and extra-embryonic cells.

Authors:  A Okuda; A Fukushima; M Nishimoto; A Orimo; T Yamagishi; Y Nabeshima; M Kuro-o; Y i Nabeshima; K Boon; M Keaveney; H G Stunnenberg; M Muramatsu
Journal:  EMBO J       Date:  1998-04-01       Impact factor: 11.598

4.  E1A represses apolipoprotein AI enhancer activity in liver cells through a pRb- and CBP-independent pathway.

Authors:  E J Kilbourne; M J Evans; S K Karathanasis
Journal:  Nucleic Acids Res       Date:  1998-04-01       Impact factor: 16.971

5.  Interferon regulatory factors and TFIIB cooperatively regulate interferon-responsive promoter activity in vivo and in vitro.

Authors:  I M Wang; J C Blanco; S Y Tsai; M J Tsai; K Ozato
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

6.  Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription.

Authors:  J C Blanco; I M Wang; S Y Tsai; M J Tsai; B W O'Malley; P W Jurutka; M R Haussler; K Ozato
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

7.  Ligand-dependent occupancy of the retinoic acid receptor beta 2 promoter in vivo.

Authors:  A Dey; S Minucci; K Ozato
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

8.  Retinoid-induced repression of human immunodeficiency virus type 1 core promoter activity inhibits virus replication.

Authors:  J W Maciaszek; S J Coniglio; D A Talmage; G A Viglianti
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  A cyclic AMP response element is involved in retinoic acid-dependent RAR beta 2 promoter activation.

Authors:  F A Kruyt; G Folkers; C E van den Brink; P T van der Saag
Journal:  Nucleic Acids Res       Date:  1992-12-11       Impact factor: 16.971

10.  Ligand modulates the conversion of DNA-bound vitamin D3 receptor (VDR) homodimers into VDR-retinoid X receptor heterodimers.

Authors:  B Cheskis; L P Freedman
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.